Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Asia
Pharma
Daiichi enlists Alteogen for subcutaneous Enhertu in $300M deal
Alteogen will use its human hyaluronidase hybridization platform to develop the subcutaneous formulation.
Zoey Becker
Nov 8, 2024 11:19am
AZ China fallout, Pfizer's $1B plan in China—Fierce Pharma Asia
Nov 8, 2024 8:54am
UPDATED: AstraZeneca stock tanks over fears of more China probe
Nov 5, 2024 3:13pm
AstraZeneca, GSK, Takeda—Fierce Pharma Asia
Nov 1, 2024 8:20am
UPDATED: Baxter exits China IV fluids market amid US shortage
Oct 30, 2024 4:55pm
BeiGene, ex-AZ exec faces investigation in China: reports
Oct 25, 2024 10:12am